2022 AWARDS
We are happy to announce that our ‘1-3 Grosvenor Square – Arrivals Court’ project is a finalist in the ‘Commercial Project of the Year’ category of the 2022 Structural Timber Awards.
Located in a historic apartment building in Grosvenor Street, London, between 2018 and 2021 a curved hybrid glulam ceiling coffered structure was created by British joinery company TMJ Interiors with the glulam timber structure supplied by HESS TIMBER.
The core of the components consists of conventional spruce glued laminated timber with the top visible layers made of the finest Walnut lamellas. This gives the timber ceiling structure an elegant and very high-quality overall appearance.

Building Client: Lodha UK
Architect: EPR Architects
Structural Engineer: Kilgallen and Partners Consulting Engineers Ltd.
Main Contractor: Mace
Joinery Company: TMJ Interiors
Glulam Supplier: HESS TIMBER

Project Information: https://lnkd.in/d46FwZwr
Shortlist Structural Timber Awards 2022: https://lnkd.in/ezmyVM5E

October 2022 – Congratulations to our client Henkel and the other design team members & construction partners Brian Dunlop Architects, Prochem, Kilgallen and Partners Consulting Engineers Ltd., MacMinn O’Reilly Mahon, and ClearyDoyle on the completion of the new entrance foyer, meeting rooms, and fit-out of the Henkel offices across 400 sq.m.

August 2024 – We are thrilled to announce that Kilgallen & Partners has been awarded Engineers Ireland’s ‘CPD Accredited Employer’ status for a further three-year period! This prestigious recognition underscores our commitment to the professional development of our engineers and technical staff. Thank you to Engineers Ireland for the accreditation, and everyone involved. Here’s to continued success and growth at Kilgallen & Partners!

1st Nov 2024 – It was great to see the new pedestrian and cycle bridge being lifted into place in the early hours this morning. The bridge is part of the Coote’s Lane Active Travel Scheme and spans 16 metres over the River Breagagh. The bridge is designed using Corten steel and it really looks the part in the autumn setting. It will be great to see the full scheme open and in use for Christmas.

Work on the new World War 1 memorial for Kilkenny City is now under way and expected to be completed in June 2018.

The memorial will recognise some 825 Kilkenny men and women who lost their lives in the Great War and acknowledge more than 3,000 men and women from Kilkenny who served in the War.

The monument is being developed at the River Nore Linear Park adjacent to Michael Street. Kilgallen & Partners provided detail design services for the project. All plaques, statues, nameplates and capping stones are being cut from Kilkenny Limestone. The works are being completed by John Somers Ltd under contract with Kilkenny County Council.

Hotel Development at 81 & 82 North Wall Quay
Kilgallen and Partners have carried out the temporary works design for this hotel development. The design includes retention of the existing protected brick façade to enable the excavation and construction of a two storey basement and the construction of a 5 storey superstructure, temporary propping of the secant pile basement wall, temporary stability of No. 81 using internal shoring whilst ensuring the protection of the existing building fabric. The temporary works solution includes the use of shipping containers as a façade retention system, which presents a sustainable, reusable solution and has already withstood the force of Hurricane Ophelia. Kilgallen and Partners wish every success to the Client and all involved.

Developer: Oakmount Ltd.
Contractor: Glenbrier Construction Ltd.

3 Storey Facade retention – Containers and Proprietary System

Street view of containers providing facade retention

Kilgallen and Partners have recently been appointed as Civil Structural Consultants for Takeda Ireland’s Bray Site Facility Upgrade for Global Standards. The project is currently at design stage with construction completion in October 2018. Takeda Pharmaceutical Company Limited is a global research-based pharmaceutical company, the No 1 pharmaceutical company in Japan, and one of the world’s top 100 companies.